The effects of Pseudomonas aeruginosa cytotoxin on the pulmonary microvasculature were studied in blood-free, perfused, isolated rabbit lungs. Cytotoxin was administered to the recirculating Krebs Henseleit albumin (1%) buffer during two consecutive 30-min-perfusion phases (phases 1 and 2) at a concentration of 13 ,ug/ml, followed by a third perfusion phase (phase 3) without toxin. After perfusion phases 2 and 3, the capillary filtration coefficient (Kf,c) and vascular compliance were determined gravimetrically from two-step microvascular pressure increments under zero-flow conditions. Cytotoxin caused a continuous release of K+ and lactate dehydrogenase, which started within the first 5 min and amounted to about 50% of the total lung cellular K+ and 5 to 7% of the total lactate dehydrogenase by the end of the experiment. The toxin caused the continuous generation of prostaglandin 12, which was detectable in the perfusates of all perfusion phases at maximum values five times above the control values and which was measured in the bronchoalveolar lavage fluid at the end of the experiment. Thromboxane generation in toxin-treated lungs did not significantly exceed that of control lungs or of lungs with mechanically induced edema. Cytotoxin caused a gradual increase in pulmonary vascular resistance, to maximum values 2.5 times above the control, starting within 1 min; the increase was partially reversible after washout of the toxin. After a lag period of 20 to 30 min, the lungs gained weight, amounting to a mean gain of 9.1 g at the end of the experiments. After perfusion phases 2 and 3, an almost fourfold increase in Kf1,, which was not reversible after washout of the toxin, was measured, whereas the values of vascular compliance were not altered. We conclude that pseudomonal cytotoxin may be an important factor in the pathogenesis of prolonged microvascular injury, encountered in states of P. aeruginosa sepsis or acute lung failure with secondarily acquired P. aeruginosa pneumonia.
Clinical studies have repeatedly shown that bacterial sepsis is the most consistent factor associated with the acute respiratory distress syndrome (ARDS) of the adult (16, 22, 24, 33, 39, 57) . During the past 30 years, Pseudomonas aeruginosa has become an increasingly important pathogen in septicemia and septic organ failure, including that of the lung (1, 2, 13, 32, 38) . Moreover, in the course of ARDS, primarily started by different underlying diseases, lung injury is often complicated by the invasion of tissue by bacteria and by nosocomial pneumonia, for which P. aeruginosa was frequently found to be responsible and which is associated with high mortality (12, 19, 23, 38, 52, 53) . Bacterial colonization and microvascular lung injury appear to be related in a vicious circle: increased rates of clearance of circulating P. aeruginosa from the lungs and a steady increase of the number of bacteria in serial lung biopsy specimens have been demonstrated in experimental models of ARDS (7, 49, 51) , whereas the infusion of live Pseudomonas organisms itself is known to mimic ARDS in sheep and pigs (5, 7, 18) . A rise in pulmonary artery pressure (PAP) and a prolonged increase in lung vascular permeability were especially noted in those experiments; these are purportedly the key alterations in the pathogenesis of ARDS. These lung microvascular lesions have been closely associated with pulmonary sequestration and stimulation of circulating granulocytes. A P. aeruginosa cytotoxin. Cytotoxin from P. aeruginosa was prepared as described previously by Lutz (30) . The preparation contains no lipid and no carbohydrate moieties, and no enzymatic activities could be measured. The absence of protease, lipase, lecithinase, alkaline phosphatase, sphingomyelinase, and phospholipase C and D activities especially has been shown (30) . There is only one protein band upon sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Portions of the toxin were stored at -20°C in phosphate-buffered saline, pH 7 (0.01 M sodium phosphate, 0.1 M sodium chloride).
Radioimmunoassay of TxB2 and 6-keto-PGFj,,. Thromboxane A2 and PGI2 were assayed serologically from the perfusion fluid and from the bronchoalveolar lavage fluid as their stable hydrolysis products, TxB2 and 6-keto-PGFi,a, as described previously (38) . The limit of detection was 5 pg for TxB2 and 10 pg for 6-keto-PGFia, and 50% binding occurred at 50 pg for TxB2 and at 170 pg for 6-keto-PGFia. Crossreactivity with other prostaglandins was <0.05% in both assays.
LDH was measured photometrically, and K+ was measured by flame photometry by standard methods.
Model of isolated lungs-general procedure. The isolatedlung model has been described previously (45, 46, 48 albumin minimizes osmotic buffering, which interferes with the pressure-step-induced fluid filtration, and avoids alterations of vascular permeability, described for isolated organs perfused in the total absence of circulating protein (20, 21) .
The determinations of Kf,C and vascular compliance were performed under zero-flow conditions to avoid any ambiguity in the height of the capillary filtration pressure. Immediately after stoppage of the perfusion flow, both the catheters to the pulmonary artery and to the left atrium were successively connected to KHAB reservoirs at 0 cm H20 (60 s), 10 cm H20 (60 s), 20 cm H20 (30 s), -10 cm H20 (60 s) , and again at 0 cm H20 (30 s). Thereafter, the perfusion fluid was exchanged, and the flow was again increased to 100 ml/min within 5 min. Thus, the entire maneuver of Kf, measurement lasted about 10 min and was performed without interruption of ventilation. KfC was calculated from the rate of lung weight gain (AW/At) during the slow phase of fluid filtration, which was taken to begin 15 s (25, 35, 56) after onset of the sudden microvascular pressure increments (AO to 10 cm H20 and A10 to 20 cm H20), and was expressed in cm3 per cm H20 per s per g (wet weight) of the lung x 10-4. The vascular compliance (40) , which is the change in the vascular volume per microvascular pressure step, was determined from the initial, rapid phase of AW induced by the AO to 10 and 10 to 20 cm H20 pressure increments. The rapid weight change was read by extrapolating the slope of the slower phase of AW to the zero time of pressure increment.
The total AW induced by one maneuver of hydrostatic challenge was determined by the difference in lung weight between the two phases of 0 microvascular pressure.
Protocol of stimulation. In 12 isolated lungs, cytotoxin was administered to the KHAB in a concentration of 13 ,g/ml in two consecutive 30-min-perfusion phases ( (Table 3) . Summing up the amounts of K+ and LDH released into the three perfusates gives a mean of 0.26 mmol and 25 U, respectively. The total K+ and LDH contents of lungs in the size used (determined after complete rinsing of the vascular bed) ranged from 0.45 to 0.52 mmol and 350 to 500 U, respectively. Thus, about 50% of the lung cellular K+ and about 5 to 7% of the lung cellular LDH was released into the circulating buffer after pseudomonal cytotoxin exposure.
In contrast to the control lungs, there was some TxB2 generation detectable 10 min after cytotoxin application. This ranged only slightly above the detection limit, however, and the TxB2 levels measured in the three perfusates after 30 min of recirculation showed no difference between the cytotoxin-treated lungs and the control lungs. In contrast, there was a marked and continuous release of 6-keto-PGF1,, into the three perfusates of the cytotoxin-treated lungs, up to maximum values five times above that of the control. As with K+ and LDH release, PGI2 formation was already detectable within the first 5 min after cytotoxin application.
In seven cytotoxin-treated lungs, in the five control lungs, and in the five separate lungs with mechanically induced edema, thromboxane and PGI2 were measured in the bronchoalveolar lavage fluid at the end of the experiments. The TxB2 values were 721 + 320 (cytotoxin-treated), 418 + 157 (mechanically induced edema), and 43 ± 28 pg/ml (control) (mean ± standard deviation). The corresponding values of 6-keto-PGFi, were 3,680 ± 1,810, 1,614 ± 408, and 147 ± 73 pg/ml. With both parameters, the edematous lungs thus differed significantly from the control lungs (P < 0.01 and P < 0.001, respectively). Additionally, the amount of 6-keto-PGFia released from the cytotoxin-treated lungs into the lavage fluid significantly exceeded the amount found in the lungs with mechanically induced edema (P < 0.05).
DISCUSSION
The effects of P. aeruginosa cytotoxin on the pulmonary microvascular bed observed in the present study can be categorized under three aspects: (i) evidence for lung cell membrane damage, (ii) induction of PGI2 generation, and (iii) increase of vascular resistance and permeability.
Evidence for lung cell membrane damage. P. aeruginosa cytotoxin effects have been studied on a variety of eucaryotic cells, including granulocytes (3, 43), endothelial cells (54, 55) , liver and hepatoma cells (14) , splenocytes (34) , and tumor cells (27) (28) (29) . The earliest symptom of toxification in these cells is an increased permeability of the plasma membrane to small ions and molecules, such as K+, Na+, Ca2+, glucose, ATP, and ruthenium red. The loss of cellular K+ especially may amount to a total of greater than 70%. Swelling of the cells due to the colloid osmotic pressure of the cellular macromolecules is assumed to cause subsequent larger membrane defects, allowing the loss of larger molecules such as LDH or protein-bound 51Cr after an initial lag period. The 
